Atezolizumab, Bevacizumab, and Chemotherapy for Newly Diagnosed Stage III or IV Ovarian Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Atezolizumab, Bevacizumab, and Chemotherapy for Newly Diagnosed Stage III or IV Ovarian Cancer: Placebo-Controlled Randomized Phase III Trial (IMagyn050/GOG 3015/ENGOT-OV39)
J. Clin. Oncol 2021 Apr 23;[EPub Ahead of Print], KN Moore, M Bookman, J Sehouli, A Miller, C Anderson, G Scambia, T Myers, C Taskiran, K Robison, J Mäenpää, L Willmott, N Colombo, J Thomes-Pepin, M Liontos, MA Gold, Y Garcia, SK Sharma, CJ Darus, C Aghajanian, A Okamoto, X Wu, R Safin, F Wu, L Molinero, V Maiya, VK Khor, YG Lin, S PignataFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.